Evidence map›Paper›PMID 41784888›Full record

GuidelineLa Radiologia medica2026

Italian guidelines for the use of digital breast tomosynthesis in breast cancer screening programmes: GRADE-ADOLOPMENT of the European guidelines.

Francesco Venturelli, Silvia Deandrea, Paola Mantellini, Eugenio Paci, Marco Zappa, Martina Rossi, Massimo Calabrese, Francesca Battisti, Lauro Bucchi, Priscilla Sassoli De' Bianchi and 13 more

Abstract readPractice Guideline
In one paragraph

Guideline in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Francesco VenturelliEpidemiology Unit, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy. francesco.venturelli@ausl.re.it.ORCID http://orcid.org/0000-0002-9190-8668
Silvia DeandreaPavia Health Protection Agency, Pavia, Italy.
Paola MantelliniInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Eugenio PaciItalian League Against Cancer, Tuscany Region Coordinator, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Marco ZappaItalian League Against Cancer, Tuscany Region Coordinator, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Martina RossiInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Massimo CalabreseIRCCS, Azienda Ospedaliera Metropolitana (AOM), Policlinico San Martino, Genoa, Italy.
Francesca BattistiInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Lauro BucchiEmilia-Romagna Cancer Registry, Romagna Cancer Institute (IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) Dino Amadori), Meldola, Italy.
Priscilla Sassoli De' BianchiDepartment of Health, Emilia-Romagna Region, Bologna, Italy.
Francesca CaumoIRCCS Istituto Oncologico Veneto IOV, Padua, Italy.
Carlo SenoreEpidemiology and screening unit - CPO - University hospital, Città Della Salute E Della Scienza, Turin, Italy.
Adriana BonifacinoFondatrice Fondazione IncontraDonna, Rome, Italy.
Flori DegrassiAssociazione Nazionale Donne Operate Al Seno - ANDOS, Rome, Italy.
Valeria FavaCittadinanzattiva, Rome, Italy.
Elisa BettiInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Riccardo VecchioDepartment of Public Health, Experimental and Forensic Medicine, University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Andrea GuidaEpidemiology Unit, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.ORCID http://orcid.org/0000-0002-1278-7053
Gian Paolo MorganoEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Livia GiordanoEpidemiology and screening unit - CPO - University hospital, Città Della Salute E Della Scienza, Turin, Italy.
Paolo Giorgi RossiEpidemiology Unit, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
Francesco SardanelliLega Italiana Per La Lotta Contro I Tumori (LILT) Milano Monza Brianza, Milan, Italy.ORCID http://orcid.org/0000-0001-6545-9427
Italian mammography screening and diagnosis guidelines Technical/Scientific Committee, Panel and Reviewers

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To enhance the quality of organized mammographic screening in Italy, in accordance with national legislation, a multidisciplinary panel of experts applied the Grading of Recommendations, Assessment, Development and Evaluation (GRADE)-ADOLOPMENT approach to adopt or adapt the European Commission Initiative on Breast Cancer (ECIBC) guidelines concerning the use of digital breast tomosynthesis (DBT). As prerequisite conditions for DBT adoption, the panel defines a full extension to women in the 45-74 age range, sufficient technical and professional resources, and an adequate monitoring system. The panel recommends the use of either DBT or digital mammography (DM) for asymptomatic women participating in organized screening programmes. However, it suggests prioritizing DBT in women with high mammographic breast density(classified as BI-RADS class c or d) when density has been previously assessed with DM. In the case of limited resources, priority in the implementation should be given to women with extremely dense breasts (BI-RADS class d). The use of DBT as an additional screening tool alongside DM is not recommended. These guidelines aim to provide a tailored approach for screening women with high mammographic breast density, improving detection while optimizing resource allocation in the context of organized screening. However, these recommendations also apply to the setting of spontaneous screening.

Indexed as

Breast NeoplasmsEarly Detection of CancerMammographyAgedBreast DensityFemaleHumansItalyMass ScreeningMiddle AgedBreast neoplasmsDigital breast tomosynthesisEuropeGRADE-ADOLOPMENTItalyMass screening

Identifiers

PMID41784888
PMCPMC13279690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.